LEFTARA 2.5 MG
létrozole
Public price
712,00 MAD
Active substance
létrozole
Laboratory
PROMOPHARM (HIKMA)
What is this medicine?
A nonsteroidal competitive inhibitor of the aromatase enzyme system that inhibits the conversion of androgens to estrogens.
Verified summary
létrozole, Comprimé enrobé, 2.5 MG, Boite de 30
Common uses
Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer, extended adjuvant treatment of postmenopausal women with early breast cancer who have received prior standard adjuvant tamoxifen therapy, and first and second-line treatment of postmenopausal women with hormone receptor positive or unknown advanced breast cancer.
Class
aromatase inhibitor
Laboratory
PROMOPHARM (HIKMA)
Hospital price
473,00 MAD
Strength
2.5 MG
Form
Comprimé enrobé
Presentation
Boite de 30
ATC code
L02BG04
Type
Générique
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 712,00 MAD
Available presentations and strengths
Medicines with the same active substance
LETROZOLE GT
2,5 MG · BOITE DE 60
1,11 MAD
LETROZOLE GT
2,5 MG · BOITE DE 10
211,00 MAD
LETROZOLE PHARMED
2,5 MG · BOITE DE 30
614,00 MAD
FEMISOL
2,5 MG · Boite de 30
630,00 MAD
LETROZOLE ZENITH
2,5 MG · BOITE DE 30
630,00 MAD
LETROZOLE ZENITH 2.5 MG
2.5 MG · Boîte de 30
630,00 MAD
LEZORA
2,5 MG · BOITE DE 28
632,00 MAD
ELOZOLE
2,5 MG · BOITE DE 30
712,00 MAD
FEMOLET
2,5 MG · BOITE DE 30
713,00 MAD
LETROZOLE COOPER
2,5 MG · BOITE DE 30
713,00 MAD
LETROZOLE GT
2.5 MG · 1 BOITE 30 COMPRIME SECABLE
713,00 MAD
LETROZOLE GT
2,5 MG · BOITE DE 30
713,00 MAD